Mark B. Stoopler
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Metastasis and carcinoma case studies
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Metastasis and carcinoma case studies 1
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Lung Cancer Research Studies 1
- Co-authors
- Joshua R. Sonett (5 shared papers)Catherine A. Shu (5 shared papers)Anjali Saqi (5 shared papers)Naiyer A. Rizvi (4 shared papers)Alain Borczuk (3 shared papers)Simon K. Cheng (3 shared papers)Balázs Halmos (3 shared papers)Michael D. Lanuti (1 shared paper)
- Journals
- American Journal of Clinical Nutrition (1 paper)Cancer Cytopathology (1 paper)The Lancet Oncology (1 paper)New England Journal of Medicine (1 paper)Clinical Lung Cancer (1 paper)
- Partner nations
- United States
In The Last Decade
Mark B. Stoopler
16 papers receiving 1.2k citations
Mark B. Stoopler's Hit Papers
Peers
Comparison fields: 5 of 61
- Pulmonary and Respiratory Medicine 673
- Oncology 502
- Cancer Research 133
- Hepatology 49
- Psychiatry and Mental health 50
Countries citing papers authored by Mark B. Stoopler
This map shows the geographic impact of Mark B. Stoopler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Stoopler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Stoopler more than expected).
Fields of papers citing papers by Mark B. Stoopler
This network shows the impact of papers produced by Mark B. Stoopler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Stoopler. The network helps show where Mark B. Stoopler may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark B. Stoopler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2020 | 462 |
| 2 | 2015 | 263 | |
| 3 | 2017 | 169 | |
| 4 | 2010 | 65 | |
| 5 | 2019 | 56 | |
| 6 | 2003 | 40 | |
| 7 | 2015 | 39 | |
| 8 | 1993 | 26 | |
| 9 | Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer. | 1982 | 19 |
| 10 | 1974 | 16 | |
| 11 | 2020 | 14 | |
| 12 | 2016 | 13 | |
| 13 | 1989 | 11 | |
| 14 | 2020 | 8 | |
| 15 | 1975 | 6 | |
| 16 | Systemic sclerosis and regional enteritis occurring simultaneously. | 1976 | 4 |
About Mark B. Stoopler
Mark B. Stoopler is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Psychiatry and Mental health and Neurology, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Metastasis and carcinoma case studies (1 paper), Lung Cancer Research Studies (1 paper), Adrenal and Paraganglionic Tumors (1 paper), Neuroblastoma Research and Treatments (1 paper) and Cardiac tumors and thrombi (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (673 citations), Oncology (502 citations), Cancer Research (133 citations), Hepatology (49 citations) and Psychiatry and Mental health (50 citations). Mark B. Stoopler has collaborated with scholars based in United States. Frequent co-authors include Joshua R. Sonett, Catherine A. Shu, Anjali Saqi, Naiyer A. Rizvi, Alain Borczuk, Simon K. Cheng, Balázs Halmos, Michael D. Lanuti, Frank D’Ovidio and Mark Awad. Their work appears in journals such as American Journal of Clinical Nutrition, Cancer Cytopathology, The Lancet Oncology, New England Journal of Medicine and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.